redalpine Closes New $250 Million Fund

The Swiss venture capital firm redalpine has announced the final closing of its new early-stage fund, redalpine capital VIII (RAC VIII). With a volume of $250 million, the fund exceeded its initial target and closed oversubscribed, according to the company.

Investors include both existing and new investors, such as Aviva Investors, Flexstone Partners, and the German development bank KfW. Additionally, entrepreneurs, executives, and high-net-worth individuals have participated.

With this new fund, redalpine continues the investment strategy it has pursued for the past 20 years. Founded in Zurich in 2006, the firm focuses on early-stage technology companies that combine scientific research with commercial applications.

Its portfolio to date includes well-known European companies such as Mistral AI, N26, Proxima Fusion, Basecamp Research, and microagi. According to its own figures, redalpine has invested in more than 100 companies in total.

The firm now manages assets of more than $1.4 billion and has expanded its original early-stage strategy into an investment platform capable of supporting companies from the seed stage through to an initial public offering (IPO).

About 20 new investments in European deep-tech startups

The new RAC VIII fund is set to invest in approximately 20 European companies. The focus is on seed and Series A funding rounds, in which redalpine intends to act primarily as the lead investor.

The initial investment amounts range from $1 million to $15 million. According to the company, redalpine reviews more than 5,000 potential investments annually.

A particular emphasis is placed on technologically sophisticated business models based on scientific developments. These include, among others, artificial intelligence, robotics, biotechnology, and new energy technologies.

Three companies are already among the new fund’s first investments:

Enact Intelligence develops technologies for the intelligent control and analysis of physical forces in robotics. Helical is working on a virtual AI lab designed to support the reproducible development of new drugs. Arlequin AI is developing an AI architecture to protect critical systems.

To evaluate such technologies, redalpine relies on an investment team with a scientific background. According to the company, about half of the employees in the investment division have training in disciplines such as biology, physics, or engineering.

With this approach, the investor aims to identify technological potential early in the development phases, when commercial applications are often not yet fully established.

European investors are strengthening their presence in the technology sector

The fundraising coincides with redalpine’s 20th anniversary. Since its founding, the firm has evolved from a single early-stage fund into an investment platform with offices in Zug, Berlin, and London, as well as a presence in Silicon Valley.

According to redalpine, twelve portfolio companies have achieved an exit since 2023. At the same time, the portfolio companies of the predecessor fund, RAC VII—which closed in 2024—have since raised a total of more than 1.1 billion U.S. dollars in additional financing.

These figures illustrate the portfolio’s performance to date but do not allow for any direct conclusions regarding the future returns of the new fund.

With RAC VIII, redalpine aims in particular to strengthen the financing of science-based technologies in Europe. The participation of institutional investors also plays an important role in this regard.

The capital commitments from Aviva Investors, Flexstone Partners, and KfW underscore the interest of major investors in European technology companies. Especially in capital-intensive sectors such as fusion energy, robotics, and biotechnology, long-term financing is crucial for transforming research findings into marketable products.

Sebastian Becker, General Partner at redalpine, sees new opportunities for European founders, particularly through artificial intelligence. Scientific expertise and the ability to solve complex technical problems could play an even greater role in determining the success of technology companies in the future.

Founding Partner Michael Sidler also points to the firm’s original investment philosophy: Since its inception, redalpine has focused on companies at the intersection of software and science.

With the closing of RAC VIII, redalpine now has an additional $250 million at its disposal to continue this strategy. This creates an additional source of funding for European deep-tech startups at a stage when building technologically sophisticated business models often requires significant investment.